ABSTRACT. At the present, the influence of intrauterine hypothyroidism on the fetus is estimated by bone age (BA). BA is also used as a predictor of later neuropsychologic development. The aim of this study was to investigate whether the neurophysiologic maturation of neonates with congenital hypothyroidism (CHT) is delayed at the start of therapy and, if so, whether this delay is comparable to that in BA. Twenty-seven infants with CHT were examined with median nerve somatosensory evoked potentials (SEP) before or within 1 wk after initiation of therapy. The effect of neonatal jaundice, a potential confounder of neonatal SEP, was also evaluated. Cervical (N13), first cephalic (N19), and second cephalic (N32) peak latencies were measured, as well as N13-N19 interval (central conduction time) and N13 latency divided by arm length. The SEP data of 103 normal infants were used as reference values. In the CHT newborns, a maturational delay was found for all SEP parameters. Preterm infants (n = 3) were conspicuously less affected than term patients. In term CHT infants, jaundice during the first postnatal week, but not late jaundice, had an additional adverse effect. SEP delay was not related to initial or actual T4 levels. BA delay exceeded SEP delay by several weeks. Our data suggest that the depressed T4 levels of the hypothyroid fetus and neonate affect the nervous tissue to a lesser degree than bone tissue and, further, that SEP is superior to BA as parameter for the evaluation of neurologic maturation of infants with CHT. (Pediatr Res 30: 34-39, 1991) 
T3, triiodothyronine
The postnatal development of the human brain has a critical period of several weeks of thyroid dependency. In CHT, treatment started after the age of 6 wk leads to more intellectual and neurologic deficits than treatment started before 6 wk of age (1, 2). But even in the group of early treated infants, defects are observed in fine motor coordination, concentration, speech, hearing, and learning (2) (3) (4) . This may be the consequence of prenatal thyroid hormone deficiency, despite substantial transplacental transport of T4 to a CHT fetus (5) . The lapse of time between birth and onset of therapy may be also a contributing factor, as well as perinatal complications such as asphyxia and jaundice, and inadequate substitution therapy (6) .
Intrauterine HT may be evaluated by BA and initial thyroid hormone levels. However, there is uncertainty about the prognostic value of either of the two parameters for the final mental development of early treated CHT patients (6, 7) . During the first week of life, the great majority of CHT infants show no neurologic abnormalities (8) , but BA is frequently retarded. To gain insight into the maturation of the CNS of these infants, more specific methods reflecting the influence of HT on the CNS are needed. VEP, brainstem auditory evoked potential, and SEP have proved valuable in this respect in adult HT (9, lo) , as well as in untreated CHT infants (1 1, 12).
In our study, SEP measurements were used to investigate whether the neurophysiologic maturation of CHT infants before or within 1 wk after initiation of therapy was delayed and, if so, to what extent the delay was related to BA and initial and actual T4 levels. SEP are influenced by neonatal jaundice (1 3) in normal newborns. Because this is a frequent complication of CHT (14) , the effect of jaundice was also evaluated in the CHT infants.
SUBJECTS AND METHODS
SEP measurements. Cervical (CS2-Fz) and cephalic (C3'/C4'-Fz) SEP were recorded as described previously (1 5). Both arms were stimulated separately. The temperature of the arms was kept constant with a thermosensor fixed in the palm of one of the hands and a thermoelement above the arms, ensuring a near nerve temperature of 36-37°C.
Recordings in newborns were made with a 2-to 100-Hz filter bandpass only. In infants older than 1 wk, this filter was used as well, and for comparison a 2-to 2000-Hz filter bandpass was used. The 2-to 100-Hz filter setting is appropriate for registration of both cephalic and cervical SEP in newborns (1 5). Calculations 14 were performed using the 2-to 100-Hz bandpass results only. according to the type of jaundice: EHB (maximum bilirubin For each recording, the results of 25-100 stimuli were averaged. value above 250 ~m o l / L during the first week), late jaundice Every recording was repeated to test reproducibility. Artefacts (LHB) (bilirubin above 170 pmol/L after 10 d), or absence of induced by movement were automatically rejected. The infants both kinds of jaundice (NonHB). The CHT/NonHB group conwere either awake or in irregular sleep. tained 11 infants (Table 1 ) and the CHT/LHB group consisted Latencies from the beginning of the stimulus to the peak of of eight neonates with bilirubin levels at the onset of therapy of the first negativity in the cervical leads (N13) as well as to the 272 + 92 Frnol/L. No preterm infants were present in these two peak of the first (N19) and second (N32) negativity in the cortical groups. The CHT/EHB group contained eight newborns, three leads were measured. CCT was defined as the N13-N19 interval. preterm (preterm CHT/EHB group, maximum bilirubin 255 f N13/AL is the N13 latency divided by the arm length, i.e. half 5 Fmol/L), and five term patients (term CHT/EHB group, the distance from wrist to wrist (caput ulnae) in ventral supine maximum bilirubin 295 f 55 Fmol/L). All were treated with position with the arms in 90" abduction. For each parameter, phototherapy, one of them with exchange transfusion. The SEP the results from the right and left side were averaged.
lags of the CHT groups were compared by means of a variance Reference values. Reference data were obtained from SEP analysis (17) . measurements of 103 normal infants with a PMA of 36-48 wk.
The interaction of early jaundice and CHT on the SEP values
The group consisted of 22 preterm infants (GA < 36.5 wk) and was evaluated by factor analysis in a 2*2*4 contingency table 8 1 term infants (GA r 36.5 wk). The selection criteria for this with four groups of term infants: with and without CHT, and group have been described previously (16) . In essence, all infants with and without EHB. The groups with CHT were identical to were in good physical health, had been admitted to the pediatric the term CHT/EHB and CHT/NonHB groups; those without ward for nonneurologic reasons, and had no major malforma-CHT consisted of two groups of normal infants. The first (contions, chromosomal abnormalities, serious illnesses, perinatal trol/EHB, n = 10, maximum bilirubin 3 13 f 52 pmol/L, PMA pathology, or abnormal thyroid screening results. For these ref-44.0 f 1.4 wk) was included in an earlier study (14) . For the erence data, the regression with PMA was determined. Linearity second group (control/NonHB, n = 18, PMA 44.2 f 1.5 wk), all of the regression lines was obtained by logarithmic transforma-term infants were selected from the reference group with a tion of the SEP values. SEP lag (ms/m or ms) was the observed postnatal age of 2 wk or more and a PMA in the same range as value minus the expected value. the CHT/EHB and CHT/NonHB groups (40.9-47.8 wk, Table  CHTpatients . Twenty-seven infants (19 girls, eight boys) with 1). The influence of these factors (CHT, EHB, and the various primary CHT were studied. They were detected by the Dutch SEP parameters) alone and in combination was tested (1 7). national CHT screening program. Besides CHT, the patients had no other congenital abnormalities. In 10 infants, the diagnosis athyroidism was made. Another 10 patients had an ectopic RESULTS thyroid gland and seven had an enzymatic defect in the thyroid Reference population. The reference group showed decreasing hormone synthesis. GA of the infants ranged from 34 to 42.5 wk SEp latencies between 36 and 48 wk pMA (Fig. 1) . The slopes and birth weight from 19 10 to 4250 g. All infants were born by of the regression lines were different for the various parameters vaginal delivery except one, who was delivered by cesarean (P < 0.001).
section. The Apgar scores after 1 min were above 6 in all cases.
CHT infants, The SEp data obtained for the CHT infants are Four patients (GA 34-37 wk) had respiratory difficulties. One of shown in Figure 1 and listed in Table 1 . A significant delay was these needed a 3-d period of assisted ventilation.
found for all SEP parameters ( Table 2 infants before the onset of therapy. Thirteen patients were tested 0.000 1 for all) (Fig. 1) . The regression coefficients of two paramat the onset and 14 within 1 wk after initiation of therapy, at eters (Nl3/AL and N19) were significantly different from those 2.5 + 2.1 d. This was not considered to introduce an important of the reference population ( p < 0.025 for both). The mean bias because SEP changes do not follow changes in thyroid PMA was 43.1 + 2.5 wk. At this age, dSEP was on the order of hormone levels directly, but within a time interval of at least 1 2-3 wk for all variables (Table 2) . wk (10) (11) (12) . Before each test informed consent was obtained BA score of the CHT infants was 8.3 _+ 2.4, whereas 11.6 + from the Parents. The project was approved by the ethical 1.7 is normal for this age (18) . dBA was 6.4 k 0.6 wk ( Table 2) . committee of the hospital. This value was larger than any of the dSEP values. BA lag After logarithmic transformation, the regression lines of the correlated with initial T4 (r = -0.52, p < 0.05), but not with SEP variables with PMA were estimated. The relations of SEP MA or the lag of any of the SEP variables. lag with BA lag and initial and actual T4 were determined. The Hyperbilirubinemia. The CHT/NonHB, CHT/LHB, and term influence of age was evaluated by comparison of the results of CHT/EHB groups all showed delayed SEP values ( Table 3 ). The the preterm and term patients by variance analysis (17) . The differences between the CHT/NonHB and the CHT/LHB group distance along the x-axis between the estimated regression lines were not significant. The SEP lag of the term CHT/EHB infants of CHT and reference infants is a linear function of PMA. This exceeded that of the CHT/NonHB neonates [ F (v = 1;56) = distance (dSEP, in weeks) was determined for each SEP param-15.43, p < 0.0051. In the same way, the SEP lag of the control/ eter, as well as for BA (dBA).
EHB group was larger than that of the controllNonHB group 5 at 45 wk PMA. T4 (nmol/L) was determined in serum at NS). The effects of EHB and CHT were independent of each the onset of therapy (initial T4) and at the day of testing (actual other (F = 1.75, NS). T4). Serum TSH concentration was above 60 mU/L in all CHT Wave form. The preterm cephalic wave form was characterized infants, with the exception of one infant who had a defect of by a large negative deflection that comprised both the N19 and thyroid globulin synthesis and a TSH of 29 mU/L. N32 peaks (Fig. 2) . At later ages these negativities became steeper Hyperbilirubinemia. CHT patients were divided into groups and better defined, due to the appearance of a positive deflection between the two peaks. The wave complex of the term CHT patients was less mature than that of the normal infants of the same PMA and resembled that of normal term neonates during the first week after birth. We did not observe abnormal wave forms in the SEP of preterm CHT patients.
DISCUSSION
Evoked potentials are particularly suited for a noninvasive evaluation of the integrity and functional maturation of a number of afferent pathways in the nervous system.
The conduction properties of the peripheral SEP pathway, as measured with N13/AL, are mainly determined by the diameter of the nerve fibers, thickness of the myelin sheet, internodal distance (1 9), and temperature (9) . Peripheral nerve conduction velocity is reduced in untreated CHT infants (20, 21) and in preterm infants with a transient hypothyroxinemia (22) . The conduction in the central pathway (N19, central conduction time, N32) is determined by maturational factors such as dentrite formation, synaptogenesis, and myelination and by factors such as sleep (1 6) and temperature (9, 19) . Perinatal problems such as asphyxia (23) , intraventricular hemorrhage (24, 25) and jaundice (1 3) can prolong the central conduction.
Because a lack of thyroid hormones results in reduced myelin (26) , synapse (27) , and dendrite formation (28) , the occurrence of neurophysiologic abnormalities in untreated CHT patients is not unexpected. The majority of our CHT patients showed prolonged latencies and immature wave patterns. These data agree with earlier studies on untreated CHT infants of comparable age. In a SEP study, prolonged central conduction times were found after median nerve stimulation (12) . A study on peripheral nerves of the lower limb revealed reduced peripheral nerve conduction velocities as well as prolonged Hoffmann's reflexes (21) . A VEP study (1 1) in older untreated CHT infants yielded consistently prolonged latencies and immature wave forms, which slowly normalized under therapy. The authors concluded that the evoked potential abnormalities reflected the delay in CNS maturation caused by CHT.
The influence of temperature must also be considered because hypothermia in adult HT patients causes an additional slowing of the peripheral and central conduction (9) . For that reason we were careful to keep the temperature of the arms at 36-37°C.
Influence ofjaundice and age. Neonatal jaundice is not rare in CHT. The incidence of EHB and LHB in our study agrees with earlier studies (14) . In normal term neonates, hyperbilirubinemia influences the brainstem auditory evoked potential (29) and SEP $ Significant difference with reference group, p < 0.000 1.
9 Significant difference with dBA, p < 0.000 1.
11 Significant difference with reference group, p < 0.001.
(1 3) results, whereas the preterm SEP seems less affected (30) . It is therefore not unexpected that in term CHT patients early jaundice caused an additional slowing of the various components of the SEP; late jaundice, however, did not. In our small preterm group, neither hyperbilirubinemia nor CHT gave significant SEP prolongations. With regard to the influence of jaundice, others reached the same conclusion studying normal preterm infants with comparable bilirubin values (30) . Why CHT would affect preterm newborns less than term babies is unclear. Lower T4 values exist in normal preterm infants than in term neonates; nevertheless, normal preterm infants' neural maturation progresses rapidly (22) . For all SEP variables of the CHT infants, a progress in maturation was found from 36 to 48 wk PMA. However, for two variables the rate of maturation was less than that of the normal infants. This means that with increasing age SEP lag becomes more pronounced. This may indicate that the SEP abnormalities are age-dependent and that in CHT during the last weeks of a term or postterm gestational period CNS maturation slows down despite substantial transplacental T4 transfer (6) and continues to do so after birth. It is likely that a longer postnatal delay of treatment will cause a more severe delay in SEP maturation, but this cannot be concluded from our data because the variation in postnatal age (2-5 wk) was too small to allow significant regressions. SEP maturation and BA. In our CHT neonates, BA delay exceeded SEP delay by several weeks. This is in accordance with clinical studies. In CHT patients investigated during the 1 st week of life (8), retarded BA and typical morphologic features such as a large tongue, dry hair, and a typical facies were identified as main indicators for CHT, whereas typical neurologic features of CHT like feeding difficulties, lethargy, and flaccidity were not. Moreover, neurologic maturation as measured with reflex patterns was mature (8) . However, by the 3rd week, the neurologic features were present in 33% of the CHT infants (31) . These studies (8, 3 I) , as well as our own study, support the hypothesis (32) that the negative effect of low T4 levels on the CNS is mitigated compared to the effect on, for instance, bone and skin tissue.
An explanation for this discrepancy may be found in the balance between the activity of the 5'DI and 5'DII deiodinating systems in the CHT fetus and newborn. The 5'DII deiodinating system predominates in brain (33) , brown adipose tissue (34) , and homogenates of the chorionic membrane decidua of the placenta (35) . The enhancement of this system in the case of low serum T4 values may explain the high local T3 production found in the cortex and cerebellum of newborn rats with HT (36, 37) . Otherwise, the 5'DI system, more prevalent in liver, kidney, and muscle (38) , is depressed in HT (36) . If bone tissue like muscle tissue (38) belongs to the 5'DI compartment, it will be dependent on circulating T3 for its metabolism and maturation (37) . This is low in severe HT. This hypothesis is supported by the weak but significant inverse relation between BA delay and T4 levels found by us and others (8) . Our study suggests that SEP maturation provides a better estimation of the activity of the cerebral 5'DII system and, therefore, of the CNS maturation of the fetus than BA.
However, within the CHT group, serum T4 and SEP abnormalities showed a poor correlation. A SEP study on adult patients with HT also demonstrated an absent relation between T4 and the VEP prolongations (39); on L-T4 treatment the latencies shortened. This observation supports the hypothesis that the T4 deficiency was the main factor responsible for the delays, despite the absence of a direct relation. Such direct relation may have been disturbed by several factors: a nonlinear relation between serum T4 and the 5'DII activity, the interference of the T4 blood-brain barrier, a time lag between T4 and SEP alterations, and, in the case of neonatal CHT, the intrauterine T4 supply and the postnatal alterations in serum T4. Inasmuch as all of these factors are well outside the scope of our study, the exact nature of the relation between the evoked potential abnormalities and serum T4 remains to be elucidated.
In conclusion, the results of our study demonstrate a delay in neurophysiologic maturation of CHT infants at initiation of therapy. The delay, however, is less severe than BA delay. Preterm CHT patients are probably less affected than term patients. Jaundice during the first postnatal week in term infants has a clear additional adverse effect, whereas for LHB no such effect could be found. Our results are in line with the clinical observation that the neurologic development of most CHT infants shortly after birth is close to normal. This may explain why many of them, if treated early, grow up without neurologic handicap. However, in a number of them, the CNS development has apparently been disturbed, perhaps in late gestation and in early postnatal life, resulting in definitive damage to the CNS. Therapy should therefore be started as early as possible. In infants with associated perinatal problems such as severe early jaundice, a more disturbed neurologic maturation may be expected.
